Showing results (351-360 of 391) with videos related to
Sort By:
Pageof 40
Science (New York, N.Y.)|March 22, 1991
The three-dimensional structure of canine parvovirus and its functional implicationsJ Tsao, M S Chapman, M Agbandje, et al.Journal of Virology|November 23, 2000
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferonX Wang, M Li, H Zheng, et al.Journal of Virology|May 1, 1995
Oligomerization of the hydrophobic heptad repeat of gp41H B Bernstein, S P Tucker, S R Kar, et al.Journal of Virology|November 24, 2012
A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvantL Martínez-Gil, P H Goff, R Hai, et al.Science (New York, N.Y.)|May 28, 1993
Protection against vaginal SIV transmission with microencapsulated vaccineP A Marx, R W Compans, A Gettie, et al.Science (New York, N.Y.)|August 26, 1983
Measurement of suppressor transfer RNA activityJ F Young, M Capecchi, F A Laski, et al.Journal of Virology|June 1, 1994
Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAST Muster, R Guinea, A Trkola, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domainsM Krystal, J F Young, P Palese, et al.Virology|September 19, 1998
Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancerN P Restifo, D R Surman, H Zheng, et al.Journal of Virology|November 1, 1993
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1S Li, V Polonis, H Isobe, et al.Pageof 40